Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases
We aimed to evaluate the compliance of physicians with the 2014 guidelines of the Japanese Society for Bone and Mineral Research, for the prevention and treatment of glucocorticoid (GC) induced osteoporosis (GIO) and to investigate the risk of fracture and other associated risk factors in bisphospho...
Guardado en:
Autores principales: | Koichiro Shinoda, Hirofumi Taki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1345e113641143f4bade84efe7eb3f29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan B, et al.
Publicado: (2015) -
Risk Factors for New Vertebral Fracture After Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures
por: Zhang ZL, et al.
Publicado: (2021) -
The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
por: Leiming Zhang, et al.
Publicado: (2021) -
Pregnancy- and lactation-associated osteoporosis with vertebral fractures: a systematic review
por: Ying Qian, et al.
Publicado: (2021) -
Osteoporosis secundaria y Osteoporosis inducida por glucocorticoides (OIG)
por: Elías Forero Illera
Publicado: (2006)